Product
GNR-084
Aliases
Anti-CD19/CD3 antibody, Cohort 1, GNR-084, Cohort 2, GNR-084, Cohort 3, GNR-084, Cohort 4, GNR-084 (2 other aliases)
1 clinical trial
3 indications
Indication
Acute Lymphoblastic LeukemiaIndication
Acute lymphoblastic leukemiaIndication
GNR-084Clinical trial
Dose-escalation Sequention Cohort Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNR-084 in Patients With Refractory or Relapse Acute Lymphoblastic B-cell Precursor Leukemia.Status: Recruiting, Estimated PCD: 2025-02-01